91 related articles for article (PubMed ID: 11682262)
1. Dopamine partial agonist reverses amphetamine withdrawal in rats.
Orsini C; Koob GF; Pulvirenti L
Neuropsychopharmacology; 2001 Nov; 25(5):789-92. PubMed ID: 11682262
[TBL] [Abstract][Full Text] [Related]
2. Effects of terguride, ropinirole, and acetyl-L-carnitine on methamphetamine withdrawal in the rat.
Hoefer ME; Voskanian SJ; Koob GF; Pulvirenti L
Pharmacol Biochem Behav; 2006 Mar; 83(3):403-9. PubMed ID: 16647107
[TBL] [Abstract][Full Text] [Related]
3. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
Schwabe K; Koch M
Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
[TBL] [Abstract][Full Text] [Related]
4. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.
Izzo E; Orsini C; Koob GF; Pulvirenti L
Pharmacol Biochem Behav; 2001 Apr; 68(4):701-8. PubMed ID: 11526967
[TBL] [Abstract][Full Text] [Related]
5. The dopamine D(2) partial agonist and antagonist terguride decreases heroin self-administration on fixed- and progressive-ratio schedules.
Zhang D; Wang X; Xiang X; Chen H; Zhang J; Su Q; Hao W
Pharmacol Biochem Behav; 2010 Dec; 97(2):222-6. PubMed ID: 20705086
[TBL] [Abstract][Full Text] [Related]
6. The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.
McDougall SA; Hernandez RM; Reichel CM; Farley CM
Psychopharmacology (Berl); 2005 Apr; 178(4):431-9. PubMed ID: 15765258
[TBL] [Abstract][Full Text] [Related]
7. Morphine withdrawal decreases responding reinforced by sucrose self-administration in progressive ratio.
Zhang D; Zhou X; Wang X; Xiang X; Chen H; Hao W
Addict Biol; 2007 Jun; 12(2):152-7. PubMed ID: 17508986
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine-induced withdrawal responding: effects of repeated drug administration.
Caul WF; Stadler JR; Barrett RJ
Psychopharmacology (Berl); 1997 Oct; 133(4):351-5. PubMed ID: 9372534
[TBL] [Abstract][Full Text] [Related]
9. Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats.
Pulvirenti L; Koob GF
Neuropsychopharmacology; 1993 May; 8(3):213-8. PubMed ID: 8507348
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat.
Pulvirenti L; Balducci C; Piercy M; Koob GF
J Pharmacol Exp Ther; 1998 Sep; 286(3):1231-8. PubMed ID: 9732383
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum.
Lee TH; Ellinwood EH; King GR
Neuropsychopharmacology; 1997 Apr; 16(4):311-4. PubMed ID: 9094149
[No Abstract] [Full Text] [Related]
12. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
Pierce RC; Kalivas PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.
Der-Avakian A; Markou A
Behav Pharmacol; 2010 Jul; 21(4):359-68. PubMed ID: 20571366
[TBL] [Abstract][Full Text] [Related]
15. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
Fletcher PJ; Tenn CC; Sinyard J; Rizos Z; Kapur S
Neuropsychopharmacology; 2007 May; 32(5):1122-32. PubMed ID: 17047670
[TBL] [Abstract][Full Text] [Related]
16. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
Russig H; Murphy CA; Feldon J
Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
[TBL] [Abstract][Full Text] [Related]
17. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
Zhornitsky S; Potvin S; Stip E; Rompré PP
Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal from chronic amphetamine reduces dopamine transmission in the rat lateral septum.
Renard GM; Sotomayor-Zarate R; Blanco EH; Gysling K
J Neurosci Res; 2014 Jul; 92(7):937-43. PubMed ID: 24753218
[TBL] [Abstract][Full Text] [Related]
19. Effect of dopamine agonists and antagonists on the lorazepam withdrawal syndrome in rats.
Nath C; Saxena RC; Gupta MB
Clin Exp Pharmacol Physiol; 2000 Mar; 27(3):167-71. PubMed ID: 10744342
[TBL] [Abstract][Full Text] [Related]
20. Effects of adenosine receptor agonists and antagonists in amphetamine-induced conditioned place preference test in rats.
Poleszak E; Malec D
Pol J Pharmacol; 2003; 55(3):319-26. PubMed ID: 14506310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
